08:00 , Jan 2, 2012 |  BioCentury  |  Finance

Potent play

Potent play Strategic investors Merck Serono Ventures and Novo A/S launched Galecto Biotech AB last week with a seed round of more than €5 million ($6.5 million) that is expected to get the biotech into the...
08:00 , Jan 22, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer ...